DVT Treatment Advances
After successful testing in South America, Bacchus Vascular was ready to begin the U.S. clinical trials for their Deep Vein Thrombosis (DVT) treatment. With 12 hospitals signed up for the trial, they required a comprehensive yet flexible information package to educate physicians and patients about their product. The materials were designed to pay special attention to parts used across all hospitals and customized parts for each trial site. The 3-month goal to sign up 40 patients was already reached halfway within the first two weeks.
Logo & Identity